While there are reports of individual gene-nutrient (e.g., APOA2, NPC1) and gene-physical activity (e.g., FTO) interactions, the generally small effect sizes of obesity-associated variants hinder reliable estimation of these interactions suggesting that only variants with robust obesity associations are likely to yield meaningful results [21]. The gene discussed is APOA2; the disease is obesity disorder.